BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27461064)

  • 21. Impact of polymorphic variation at 7p15.3, 3p22.1 and 2p23.3 loci on risk of multiple myeloma.
    Martino A; Campa D; Jamroziak K; Reis RM; Sainz J; Buda G; García-Sanz R; Lesueur F; Marques H; Moreno V; Jurado M; Ríos R; Szemraj-Rogucka Z; Szemraj J; Tjønneland A; Overvad K; Vangsted AJ; Vogel U; Mikala G; Kádár K; Szombath G; Varkonyi J; Orciuolo E; Dumontet C; Gemignani F; Rossi AM; Landi S; Petrini M; Houlston RS; Hemminki K; Canzian F
    Br J Haematol; 2012 Sep; 158(6):805-9. PubMed ID: 22823248
    [No Abstract]   [Full Text] [Related]  

  • 22. A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci.
    Rand KA; Song C; Dean E; Serie DJ; Curtin K; Sheng X; Hu D; Huff CA; Bernal-Mizrachi L; Tomasson MH; Ailawadhi S; Singhal S; Pawlish K; Peters ES; Bock CH; Stram A; Van Den Berg DJ; Edlund CK; Conti DV; Zimmerman T; Hwang AE; Huntsman S; Graff J; Nooka A; Kong Y; Pregja SL; Berndt SI; Blot WJ; Carpten J; Casey G; Chu L; Diver WR; Stevens VL; Lieber MR; Goodman PJ; Hennis AJ; Hsing AW; Mehta J; Kittles RA; Kolb S; Klein EA; Leske C; Murphy AB; Nemesure B; Neslund-Dudas C; Strom SS; Vij R; Rybicki BA; Stanford JL; Signorello LB; Witte JS; Ambrosone CB; Bhatti P; John EM; Bernstein L; Zheng W; Olshan AF; Hu JJ; Ziegler RG; Nyante SJ; Bandera EV; Birmann BM; Ingles SA; Press MF; Atanackovic D; Glenn MJ; Cannon-Albright LA; Jones B; Tricot G; Martin TG; Kumar SK; Wolf JL; Deming Halverson SL; Rothman N; Brooks-Wilson AR; Rajkumar SV; Kolonel LN; Chanock SJ; Slager SL; Severson RK; Janakiraman N; Terebelo HR; Brown EE; De Roos AJ; Mohrbacher AF; Colditz GA; Giles GG; Spinelli JJ; Chiu BC; Munshi NC; Anderson KC; Levy J; Zonder JA; Orlowski RZ; Lonial S; Camp NJ; Vachon CM; Ziv E; Stram DO; Hazelett DJ; Haiman CA; Cozen W
    Cancer Epidemiol Biomarkers Prev; 2016 Dec; 25(12):1609-1618. PubMed ID: 27587788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association between the PTPN22 1858C>T variant and type 1 diabetes depends on HLA risk and GAD65 autoantibodies.
    Maziarz M; Janer M; Roach JC; Hagopian W; Palmer JP; Deutsch K; Sanjeevi CB; Kockum I; Breslow N; Lernmark A; ;
    Genes Immun; 2010 Jul; 11(5):406-15. PubMed ID: 20445565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implementation of genome-wide complex trait analysis to quantify the heritability in multiple myeloma.
    Mitchell JS; Johnson DC; Litchfield K; Broderick P; Weinhold N; Davies FE; Gregory WA; Jackson GH; Kaiser M; Morgan GJ; Houlston RS
    Sci Rep; 2015 Jul; 5():12473. PubMed ID: 26208354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome-wide scan identifies variant in 2q12.3 associated with risk for multiple myeloma.
    Erickson SW; Raj VR; Stephens OW; Dhakal I; Chavan SS; Sanathkumar N; Coleman EA; Lee JY; Goodwin JA; Apewokin S; Zhou D; Epstein J; Heuck CJ; Vangsted AJ
    Blood; 2014 Sep; 124(12):2001-3. PubMed ID: 25237182
    [No Abstract]   [Full Text] [Related]  

  • 26. Association of the HLA-G gene polymorphism with multiple sclerosis in a Polish population.
    Wiśniewski A; Bilińska M; Klimczak A; Wagner M; Majorczyk E; Nowak I; Pokryszko-Dragan A; Kuśnierczyk P
    Int J Immunogenet; 2010 Aug; 37(4):307-11. PubMed ID: 20636826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variants near the HLA complex group 22 gene (HCG22) confer increased susceptibility to late-onset asthma in Japanese populations.
    Yatagai Y; Hirota T; Sakamoto T; Yamada H; Masuko H; Kaneko Y; Iijima H; Naito T; Noguchi E; Tamari M; Kubo M; Takahashi A; Konno S; Makita H; Nishimura M; Hijikata M; Keicho N; Homma S; Taguchi Y; Azuma A; Kudoh S; Hizawa N
    J Allergy Clin Immunol; 2016 Jul; 138(1):281-283.e13. PubMed ID: 26830115
    [No Abstract]   [Full Text] [Related]  

  • 28. Genetic predisposition for multiple myeloma.
    Pertesi M; Went M; Hansson M; Hemminki K; Houlston RS; Nilsson B
    Leukemia; 2020 Mar; 34(3):697-708. PubMed ID: 31913320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nasopharyngeal carcinoma MHC region deep sequencing identifies HLA and novel non-HLA TRIM31 and TRIM39 loci.
    Ning L; Ko JM; Yu VZ; Ng HY; Chan CK; Tao L; Lam SY; Leong MM; Ngan RK; Kwong DL; Lee AW; Ng WT; Cheng A; Tung S; Lee VH; Lam KO; Kwan CK; Li WS; Yau S; Bei JX; Lung ML
    Commun Biol; 2020 Dec; 3(1):759. PubMed ID: 33311639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of TLR-IFN and HLA polymorphisms on susceptibility of chronic HBV infection in Southwest Han Chinese.
    He D; Tao S; Guo S; Li M; Wu J; Huang H; Guo X; Yan G; Zhu P; Wang Y
    Liver Int; 2015 Aug; 35(8):1941-9. PubMed ID: 25469587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA and non-HLA genes in Behçet's disease: a multicentric study in the Spanish population.
    Montes-Cano MA; Conde-Jaldón M; García-Lozano JR; Ortiz-Fernández L; Ortego-Centeno N; Castillo-Palma MJ; Espinosa G; Graña-Gil G; González-Gay MA; Barnosi-Marín AC; Solans R; Fanlo P; Camps T; Castañeda S; Sánchez-Bursón J; Núñez-Roldán A; Martín J; González-Escribano MF
    Arthritis Res Ther; 2013 Oct; 15(5):R145. PubMed ID: 24286189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic aspects of susceptibility to multiple myeloma.
    Ludwig H; Mayr W
    Blood; 1982 Jun; 59(6):1286-91. PubMed ID: 6952946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [HLA markers in myeloma and benign monoclonal dysglobulinemias].
    Cassuto JP; Piereschi J; Maiolini R; Dujardin P; Ribeil R; Masseyeff R
    Nouv Presse Med; 1981 Jan; 10(4):252-3. PubMed ID: 7465363
    [No Abstract]   [Full Text] [Related]  

  • 34. Role of genetic susceptibility variants in predicting clinical course in multiple sclerosis: a cohort study.
    Pan G; Simpson S; van der Mei I; Charlesworth JC; Lucas R; Ponsonby AL; Zhou Y; Wu F; Taylor BV
    J Neurol Neurosurg Psychiatry; 2016 Nov; 87(11):1204-1211. PubMed ID: 27559181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HLA and multiple myeloma among black and white men: evidence of a genetic association.
    Pottern LM; Gart JJ; Nam JM; Dunston G; Wilson J; Greenberg R; Schoenberg J; Swanson GM; Liff J; Schwartz AG
    Cancer Epidemiol Biomarkers Prev; 1992; 1(3):177-82. PubMed ID: 1306102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Multinational Arab Genome-Wide Association Study Identifies New Genetic Associations for Rheumatoid Arthritis.
    Saxena R; Plenge RM; Bjonnes AC; Dashti HS; Okada Y; Gad El Haq W; Hammoudeh M; Al Emadi S; Masri BK; Halabi H; Badsha H; Uthman IW; Margolin L; Gupta N; Mahfoud ZR; Kapiri M; Dargham SR; Aranki G; Kazkaz LA; Arayssi T
    Arthritis Rheumatol; 2017 May; 69(5):976-985. PubMed ID: 28118524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic variants in the human leukocyte antigen region and survival of Chinese patients with non-small cell lung carcinoma.
    Cheng L; Liu Q; Wang M; Gu Y; Wang J; Wei Q; Zhang R
    Carcinogenesis; 2020 Sep; 41(9):1203-1212. PubMed ID: 32614429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region.
    Skibola CF; Berndt SI; Vijai J; Conde L; Wang Z; Yeager M; de Bakker PI; Birmann BM; Vajdic CM; Foo JN; Bracci PM; Vermeulen RC; Slager SL; de Sanjose S; Wang SS; Linet MS; Salles G; Lan Q; Severi G; Hjalgrim H; Lightfoot T; Melbye M; Gu J; Ghesquières H; Link BK; Morton LM; Holly EA; Smith A; Tinker LF; Teras LR; Kricker A; Becker N; Purdue MP; Spinelli JJ; Zhang Y; Giles GG; Vineis P; Monnereau A; Bertrand KA; Albanes D; Zeleniuch-Jacquotte A; Gabbas A; Chung CC; Burdett L; Hutchinson A; Lawrence C; Montalvan R; Liang L; Huang J; Ma B; Liu J; Adami HO; Glimelius B; Ye Y; Nowakowski GS; Dogan A; Thompson CA; Habermann TM; Novak AJ; Liebow M; Witzig TE; Weiner GJ; Schenk M; Hartge P; De Roos AJ; Cozen W; Zhi D; Akers NK; Riby J; Smith MT; Lacher M; Villano DJ; Maria A; Roman E; Kane E; Jackson RD; North KE; Diver WR; Turner J; Armstrong BK; Benavente Y; Boffetta P; Brennan P; Foretova L; Maynadie M; Staines A; McKay J; Brooks-Wilson AR; Zheng T; Holford TR; Chamosa S; Kaaks R; Kelly RS; Ohlsson B; Travis RC; Weiderpass E; Clavel J; Giovannucci E; Kraft P; Virtamo J; Mazza P; Cocco P; Ennas MG; Chiu BC; Fraumeni JF; Nieters A; Offit K; Wu X; Cerhan JR; Smedby KE; Chanock SJ; Rothman N
    Am J Hum Genet; 2014 Oct; 95(4):462-71. PubMed ID: 25279986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-nucleotide polymorphism rs1052501 associated with monoclonal gammopathy of undetermined significance and multiple myeloma.
    Greenberg AJ; Lee AM; Serie DJ; McDonnell SK; Cerhan JR; Liebow M; Larson DR; Colby CL; Norman AD; Kyle RA; Kumar S; Rajkumar SV; Diasio RB; Slager SL; Vachon CM
    Leukemia; 2013 Feb; 27(2):515-6. PubMed ID: 22945773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Caspase polymorphisms and genetic susceptibility to multiple myeloma.
    Hosgood HD; Baris D; Zhang Y; Zhu Y; Zheng T; Yeager M; Welch R; Zahm S; Chanock S; Rothman N; Lan Q
    Hematol Oncol; 2008 Sep; 26(3):148-51. PubMed ID: 18381704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.